The UCLA David Geffen School of Medicine has received a $15.2 million bequest from the estate of entertainer Garry Shandling.
The university on Feb. 5 announced the gift from the late comedian, actor, director, writer and producer who died in 2016.
The funds will go toward advancing research in endocrinology, diabetes and hypertension, in addition to infectious and pancreatic diseases.
“Innovative medical discoveries and breakthrough therapies developed at UCLA have greatly enhanced – and saved – countless lives,” said Gene Block, chancellor at the Westwood university. “Garry Shandling’s bequest is a testament to his belief in what is possible at UCLA, and we are fortunate to have merited his support.”
Shandling had expressed gratitude to doctors at Ronald Reagan UCLA Medical Center, where he had undergone surgery for hyperparathyroidism, a rare condition that can cause heart attacks.
His gift will establish a Garry Shandling Endocrine Surgery Research Fund, a Garry Shandling Infectious Diseases Innovation Fund, a Garry Shandling Pancreatic Diseases Fund and a Garry Shandling Medical Research Fund.
In his honor, UCLA has named a Garry Shandling Learning Studio, a 6,400-square-foot multipurpose room inside Geffen Hall, the school’s medical education building.
Health business reporter Dana Bartholomew can be reached at firstname.lastname@example.org. Follow him on Twitter @_DanaBart.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- UCLA Receives $25 Million Gift for Parkinson’s Research
- UCLA Receives $2.7 Million to Help Adults With HIV Ward Off Heart Disease
- UCLA Awarded $20 Million to Rebuild Medical Plaza and Conduct Research
- L.A. Plastic Surgeons Get Top Marks
- $20M Gift to UCLA for State-of-the-Art Medical Simulation Center
- National Academy of Medicine Taps UCLA Neurosurgeon
- UCLA Leads the Nation in Organ Transplants
- UCLA Receives $5M Federal Grant to Study Early Lung Cancer Detection